https://orcid.org/0000-0003-4276-9451
References
- Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–167.
- Gibran A, Muhammad AT, Kamran S, et al. Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment. Gene Ther. 2021;28(1–2):6–15.
- Muncie HL Jr, Campbell J. Alpha and β thalassemia. Am Fam Physician. 2009;80(4):339–344.
- Xu X, Wu X. Epidemiology and treatment of β thalassemia major in China. Pediatr Investig. 2020;4(1):43–47.
- Wei X-F, Shang X, He D-Q, et al. Molecular characterization of a novel 27.6-kb deletion causing α(+) thalassemia in a Chinese family. Ann Hematol. 2011;90(1):17–22.
- Kountouris P, Lederer CW, Fanis P, et al. IthaGenes: an interactive database for haemoglobin variations and epidemiology. PLOS One. 2014;9(7):e103020.
- Traivaree C, Boonyawat B, Monsereenusorn C, et al. Clinical and molecular genetic features of Hb H and AE Bart’s diseases in central Thai children. Appl Clin Genet. 2018;11:23–30.
- Mondal SK, Mandal S. Prevalence of thalassemia and hemoglobinopathy in eastern India: a 10-year high-performance liquid chromatography study of 119,336 cases. Asian J Transfus Sci. 2016;10(1):105–110.
- Ngim CF, Lee MY, Othman N, et al. Prevalence and risk factors for cardiac and liver iron overload in adults with thalassemia in Malaysia. Hemoglobin. 2019;43(2):95–100.
- Kulaphisit M, Kampuansai J, Leecharoenkiat K, et al. A comprehensive ethnic-based analysis of α thalassaemia allelle frequency in northern Thailand. Sci Rep. 2017;7(1):4690.
- Huang H, Xu L, Chen M, et al. Molecular characterization of thalassemia and hemoglobinopathy in Southeastern China. Sci Rep. 2019;9(1):3493.
- Yang Z, Cui Q, Zhou W, et al. Comparison of gene mutation spectrum of thalassemia in different regions of China and Southeast Asia. Mol Genet Genomic Med. 2019;7(6):e680.
- Lin M, Zhong T-Y, Chen Y-G, et al. Molecular epidemiological characterization and health burden of thalassemia in Jiangxi Province, P. R. China. PLOS One. 2014;9(7):e101505.
- Tan M, Bai Y, Zhang Y, et al. Early genetic screening uncovered a high prevalence of thalassemia among 18 309 neonates in Guizhou, China. Clin Genet. 2021;99(5):704–712.
- Gan J, Ding F, Liu H. Analysis of thalassemia-related mutations in Pingxiang area of Jiangxi [in Chinese]. Zhong Xue Chuan Xue Zhi. 2020;37(10):1101–1103.
- Lai K, Huang G, Su L, et al. The prevalence of thalassemia in mainland china: evidence from epidemiological surveys. Sci Rep. 2017;7:920.
- Yan Y, Yang Z, Yu H, et al. High prevalence of thalassemia with a novel α-thalassemia mutation in Baoan populations in Guangdong province, China. Eur J Obstet Gynecol Reprod Biol. 2020;255:263–265.
- Li B, Zhang X-Z, Yin A-H, et al. High prevalence of thalassemia in migrant populations in Guangdong province, China. BMC Public Health. 2014;14:905.
- Lin Y-H, Lin W, Wang X-X. [Genotyping of patients with α and β thalassemia in Fujian Province]. [in Chinese]. Zhongguo Shi Yan Xue Za Zhi. 2019;27(3):899–903.
- Wang X-Y, Lin M-X, Lin M. A novel 6.3 kb deletion and the rare 27.6 kb deletion causing α+-thalassemia in two Chinese patients. Hemoglobin. 2016;40(5):365–368.
- Peng Q, Zhang Z, Li S, et al. Molecular epidemiological and hematological profile of thalassemia in the Dongguan Region of Guangdong Province, Southern China. J Clin Lab Anal. 2021;35(2):e23596.
- Zhuang J, Jiang Y, Wang Y, et al. Molecular analysis of α-thalassemia and β-thalassemia in Quanzhou region Southeast China. J Clin Pathol. 2020;73(5):278–282.